Commit Biologics appoints scientific advisory board

Company
Commit Biologics ApS
Appointee name
Janine Schuurman, Mikkel Wandahl Pedersen, Paul Parren, Gavin Thurston, Susan Kalled and Esper Boel
Country

Denmark

Commit Biologics ApS, a developer of new drugs for cancer and autoimmune diseases, has formed a scientific advisory board with experts in drug development and immunology. The board will be co-chaired by Janine Schuurman, an antibody expert and former Genmab executive, and Commit's CEO Mikkel Wandahl Pedersen. They will be joined by four members: Paul Parren, a professor of molecular immunology and biotech entrepreneur; Gavin Thurston, an R&D executive and former senior vice president of oncology research at Regeneron; Susan Kalled, an immunologist and formerly chief scientific officer at Dianthus Therapeutics and Compass Therapeutics; and Esper Boel, a molecular biologist and former senior executive at Novo Nordisk. 

Copyright 2025 Evernow Publishing Ltd